Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

CLB

Core Labs

NYSE

Real-time Quotes | Nasdaq Last Sale

27.50

-0.26

-0.94%

After Hours: 27.50 0 0.00% 16:31 09/17 EDT

OPEN

27.58

PREV CLOSE

27.76

HIGH

27.78

LOW

27.24

VOLUME

763.27K

TURNOVER

52 WEEK HIGH

49.87

52 WEEK LOW

13.43

MARKET CAP

1.27B

P/E (TTM)

37.82

Core Laboratories N.V. (NYSE:CLB) Delivered A Better ROE Than Its Industry

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St. · 1d ago

Why Is Core Laboratories (CLB) Down 19.4% Since Last Earnings Report?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks · 08/27 15:31

Piper Sandler Adjusts Core Laboratories' Price Target to $17.50 From $20, Maintains Neutral Rating

MT Newswires · 08/20 10:07

Here’s Why You Should Invest in Core Laboratories (CLB)

Alger, an investment management firm, published its “Alger Weatherbie Specialized Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. During the quarter, the largest portfolio sector weightings were Financials and Hea...

Insider Monkey · 08/13 16:56

Morgan Stanley Maintains Equal-Weight on Core Laboratories, Lowers Price Target to $37

Morgan Stanley maintains Core Laboratories (NYSE:CLB) with a Equal-Weight and lowers the price target from $40 to $37.

Benzinga · 08/03 12:36

Core Laboratories (NYSE:CLB) May Have Issues Allocating Its Capital

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...

Simply Wall St. · 08/03 06:47

Core Labs' (CLB) Q2 Earnings and Revenues Miss Estimates

Zacks.com · 08/02 15:32

--Morgan Stanley Adjusts Price Target for Core Laboratories N.V to $37 From $40, Maintains Equalweight Rating

MT Newswires · 08/02 14:48

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of CLB. Analyze the recent business situations of Core Labs through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 11 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CLB stock price target is 30.85 with a high estimate of 54.00 and a low estimate of 17.00.

EPS

Institutional Holdings

Institutions: 415

Institutional Holdings: 62.37M

% Owned: 134.61%

Shares Outstanding: 46.33M

TypeInstitutionsShares

Increased

5.73M

New

979.35K

Decreased

2.81M

Sold Out

700.07K

Performance
Asset Allocation
Dividend History

No Data

Industry

Oil Related Services and Equipment

-2.42%

Oil & Gas Related Equipment and Services

-1.48%

Key Executives

Chairman - Supervisory/President/Chief Executive Officer/Chief Operating Officer/Director

Lawrence Bruno

Chief Financial Officer/Senior Vice President

Christopher Hill

General Counsel/Secretary

Mark Elvig

Lead Director/Independent Director

Martha Carnes

Independent Director/Supervisory Board

Gregory Barnett

Independent Director/Supervisory Board

Harvey Klingensmith

Independent Director/Supervisory Board

Michael Straughen

Independent Director/Supervisory Board

Monique Van Dijken Eeuwijk

Declaration Date Dividend Per Share Ex-Div Date: 07/28/2021
Dividend USD 0.01
08/06/2021; 04/21/2021
Dividend USD 0.01
04/30/2021; 01/15/2021
Dividend USD 0.01
01/22/2021; 10/15/2020
Dividend USD 0.01
10/23/2020; 07/17/2020
Dividend USD 0.01
07/24/2020; 04/28/2020
Dividend USD 0.01
05/07/2020; 01/14/2020
Dividend USD 0.25
01/23/2020; 10/08/2019
Dividend USD 0.55
10/17/2019; 07/12/2019
Dividend USD 0.55
07/19/2019; 04/16/2019
Dividend USD 0.55
04/25/2019; 01/15/2019
Dividend USD 0.55
01/24/2019; 10/09/2018
Dividend USD 0.55
10/18/2018; 07/13/2018
Dividend USD 0.55
07/20/2018; 04/17/2018
Dividend USD 0.55
04/26/2018; 01/16/2018
Dividend USD 0.55
01/25/2018; 10/10/2017
Dividend USD 0.55
10/19/2017; 07/07/2017
Dividend USD 0.55
07/13/2017; 04/19/2017
Dividend USD 0.55
04/26/2017; 01/11/2017
Dividend USD 0.55
01/18/2017; 10/12/2016
Dividend USD 0.55
10/19/2016

All
Financials
Insiders

About CLB

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Webull offers kinds of Core Laboratories N.V. stock information, including NYSE:CLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CLB stock methods without spending real money on the virtual paper trading platform.